MedTrace Logo

Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg

NCT00427960 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2010-12-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the effectiveness and safety of rosuvastatin 5mg in lowering blood cholesterol, compared to one other medicine, atorvastatin 10mg in Asian patients in the UK.

Conditions

  • Hypercholesterolaemia

Interventions

BEHAVIORAL

Dietary advice

DRUG

rosuvastatin

rosuvastatin 5 mg

DRUG

atorvastatin

atorvastatin 10 mg

Sponsors & Collaborators

Principal Investigators

  • Rhiannon Rowsell, MD · AstraZeneca

  • Shahid Ali, MD · Bradford PCT

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00427960 on ClinicalTrials.gov